Detalles de la búsqueda
1.
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
Cancer
; 130(4): 541-552, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843249
2.
Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women.
Eur J Haematol
; 111(3): 449-457, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37308461
3.
The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation.
BMC Cancer
; 22(1): 997, 2022 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36127634
4.
Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study.
BMC Palliat Care
; 20(1): 58, 2021 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849508
5.
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act.
BMC Palliat Care
; 20(1): 63, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906659
6.
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
Cancer
; 126(20): 4521-4531, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749686
7.
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
BMC Cancer
; 20(1): 1193, 2020 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276759
8.
CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia.
BMC Cancer
; 20(1): 285, 2020 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32252668
9.
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Lancet Oncol
; 20(12): 1681-1690, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31587882
10.
Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression.
Tumour Biol
; 41(5): 1010428319848612, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31074363
11.
Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07).
Br J Cancer
; 118(5): 648-653, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29381690
12.
Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads.
Jpn J Clin Oncol
; 46(12): 1095-1101, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27677660
13.
Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.
Nucleic Acids Res
; 41(11): 5614-25, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23595149
14.
CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model.
Invest New Drugs
; 32(3): 400-11, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24202729
15.
Ectopic over-expression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28.
Nucleic Acids Res
; 40(9): 3856-69, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22210895
16.
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.
Cancer Res Treat
; 56(1): 48-60, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402411
17.
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study.
Cancer Res Treat
; 56(2): 404-413, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37933112
18.
Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells.
J Biol Chem
; 287(34): 28770-8, 2012 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-22700982
19.
A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia.
Blood
; 118(14): 3832-41, 2011 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-21828126
20.
Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301.
J Thorac Oncol
; 18(10): 1351-1361, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37702629